Navigation Links
Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009
Date:6/8/2009

Analysis of Subjects with Moderately Severe Diabetic Neuropathy Shows Statistically Significant Improvement in Multiple Quantitative Neurological Endpoints

RICHMOND, Calif., June 8 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the presentation of as yet unreleased positive Phase 2 clinical data from its ZFP Therapeutic(TM) program to develop SB-509 as a treatment for diabetic neuropathy (DN) at the 69th Annual Scientific Sessions of the American Diabetes Association (ADA), held in New Orleans, LA, from June 5 to 9, 2009. Data from Sangamo's SB-509-601 and SB-509-701A Phase 2 clinical trials demonstrated that SB-509 treatment resulted in statistically significant and clinically relevant improvements in subjects with moderate and severe DN as compared to placebo. SB-509 was well-tolerated in both multi-dose studies.

"We have learned a great deal from these data, which demonstrate positive activity of SB-509 in multiple clinically relevant measurements of nerve health," stated Dale Ando, M.D., Sangamo's Vice President of Therapeutic Development and Chief Medical Officer. "Data from our Phase 1 and both Phase 2 clinical trials have shown us that the dual angiogenic and neurotrophic effects of SB-509 are most effective in the later stages of DN when both diabetic microvascular disease and metabolic neuropathy are evident. The statistically significant improvement in SB-509-treated subjects across multiple independent clinical endpoints for DN has enabled definition of a responder group and is particularly encouraging for future trials in this patient population."

"SB-509 is the first drug candidate of its type designed to harness the body's own regenerative potential to address DN, a significant complication for diabetic patients," stated Alan Lewis, Ph.D., President and Chief
'/>"/>

SOURCE Sangamo
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Sangamo BioSciences Announces Presentation at the JMP Securities Research Conference
2. Sangamo BioSciences Reports First Quarter 2009 Financial Results
3. Sangamo BioSciences Provides Update on Companys Accomplishments in 2007 and 2008 Objectives
4. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
5. BD Biosciences Launches New Cell Analyzer for Complex Multicolor Experiments in Disease and Drug Development Research
6. ImQuest BioSciences and Arisyn Therapeutics Introduce Novel New HCV Therapeutic Agent at Hepatitis Conference
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2009 Financial Results
8. Stem Cell Biotherapy Sues Casey Nabavi, Co-Founder and Former President, for Conduct Resulting in Claims by SCB Patients Against Nabavi, Embezzling Money and Converting Other Assets Belonging to SCB and for Wrongfully Establishing Cellulogix Biosciences t
9. Epiphany Biosciences Initiates Program to Assess Valomaciclovir (EPB-348) as Adjunctive Therapy in Multiple Sclerosis (MS)
10. Pressure BioSciences, Inc. Provides Corporate Update
11. BIND Biosciences To Install First Siemens Simatic(R) PCS 7 Lab Process Control System in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2015)... 23, 2015 With the implementation of ... finding it increasingly difficult to provide their employees with ... provide adequate insurance for employees stand to face strict ... an integral part of a business’s success or failure. ... businesses, Online USA Doctors has created a varying level ...
(Date:5/23/2015)... Javon Bea Mercy Health System CEO ... Center, 557 N. Washington St., Janesville, will host an ... pm. , The 8-week clinic is lead by Brent ... who will offer training that encompasses a warm-up, training ... show selection and weekly training plans. , The program ...
(Date:5/22/2015)... May 22, 2015 The American College ... events in June. They will hold a webinar on ... a two-day class on Classical Chinese Medicine. , Webinar ... Dr. Steve Given, the Dean of Clinical Education, will ... new First Professional Doctorate program. ACTCM is currently developing ...
(Date:5/22/2015)... May 22, 2015 Omar Ahmad Barrada, ... to participate in the 2015 Congress of Future Medical ... as a gathering of “America’s highest achieving high school ... of healthcare, set new goals and learn better study ... live surgery, during which we can ask the surgeons ...
(Date:5/22/2015)... May 22, 2015 Carnegie Science ... today announced a new partnership to develop BodyTech, a ... region. The initiative includes a new exhibit at the ... demonstration theater, and a new traveling science show, Anatomy ... of 2015. , Designed to explore a wide ...
Breaking Medicine News(10 mins):Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:ACTCM Announces Upcoming June Events 2Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4
... our mouths use to invade heart tissue, causing a dangerous and ... raises the possibility of creating a screening tool perhaps a ... a dental patient,s vulnerability to the condition. The identification of ... foothold in heart tissue is reported in the June issue of ...
... a mastectomy for women with advanced breast cancer saves lives, ... That is the conclusion of a new study published early ... American Cancer Society. The study,s results indicate that treatments that ... be available to many patients. , After clinical trials in ...
... the Phase I clinical trial of the generic drug ... were announced today at the American Diabetes Association scientific ... by Denise Faustman, MD, PhD, director of the Massachusetts ... (No. 2240-PO and No. 0057-LB) the first which ...
... Dietary changes alone can yield the same benefits as changes ... a person is diagnosed with type 2 diabetes, a new ... encouraged to lose weight by modifying their diet with the ... sugar (glycemic) control, weight loss, cholesterol and triglyceride levels as ...
... By Jenifer Goodwin HealthDay Reporter , FRIDAY, June ... they meet a lot of engineers and computer programmers who ... suggests there may be merit to those observations. Researchers ... as many children were diagnosed with an autism spectrum disorder ...
... NY Joanna Fowler, a senior chemist and director ... U.S. Department of Energy,s Brookhaven National Laboratory, is one ... been chosen to receive a Distinguished Women in Chemistry/Chemical ... The awards will be given as part ...
Cached Medicine News:Health News:How cavity-causing microbes invade heart 2Health News:How cavity-causing microbes invade heart 3Health News:Many advanced breast cancer patients do not receive recommended treatment 2Health News:Massachusetts General Hospital, Iacocca Foundation announce promising results of Phase I diabetes trial 2Health News:Massachusetts General Hospital, Iacocca Foundation announce promising results of Phase I diabetes trial 3Health News:After Diabetes Diagnosis, Concentrate on Dietary Changes, Study Says 2Health News:After Diabetes Diagnosis, Concentrate on Dietary Changes, Study Says 3Health News:More Autism Diagnoses in High-Tech Areas, Study Finds 2Health News:More Autism Diagnoses in High-Tech Areas, Study Finds 3Health News:Brookhaven Lab's Joanna Fowler receives Distinguished Women in Chemistry Award 2Health News:Brookhaven Lab's Joanna Fowler receives Distinguished Women in Chemistry Award 3
(Date:5/21/2015)... 2015  CryoLife, Inc. (NYSE: CRY ), a ... cardiac and vascular surgery, announced today that its Board ... the second quarter 2015 of $0.03 per share of ... per share will be paid on June 19, 2015 ... 12, 2015.  The ex-dividend date for the quarterly dividend ...
(Date:5/21/2015)... -- The Pharmaceutical Care Management Association (PCMA) issued ... offsets included in the Energy & Commerce Committee,s ... 21st Century Cures initiative can only be advanced by ... Medicare – then its costs outweigh any potential ... "Leveraging payments to Part D plans to ...
(Date:5/21/2015)... , May 21, 2015  Heidrick & Struggles (Nasdaq: ... search , leadership consulting and culture ... expertise among global practices announcing the addition of ... office. Dietlin has extensive ... globally and across R&D, Medical and Commercial functions to ...
Breaking Medicine Technology:CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2Heidrick Increases Healthcare and Life Sciences Expertise 2
... 2011 Cognizant (Nasdaq: CTSH ... process outsourcing (BPO) services, announced that it has been ... leading innovation-driven pharmaceutical companies, to deliver an end-to-end set ... operations be more effective, efficient, and innovative. ...
... 2010 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... and marketer of medical devices worldwide, together with ... today announced Mindray North America,s largest order of ... patient monitors has already begun at the Centre ...
Cached Medicine Technology:Cognizant Selected by Lilly to Deliver Commercial Operations Solutions to Enhance Sales and Marketing Effectiveness, Business Performance 2Cognizant Selected by Lilly to Deliver Commercial Operations Solutions to Enhance Sales and Marketing Effectiveness, Business Performance 3Mindray Receives its Largest Order of Patients Monitors in Canada 2
The Linvatec 3mm and 5mm Universal Light Guides are autoclavable. They offer flexibility, superior light transmission, and universal fittings in a lightweight package....
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
... EndoEYE offers a revolutionary new ... a miniaturized CCD chip right ... fragile rod lenses a thing ... your eye right at the ...
... The ALU-2B Halogen Light Source ... with the addition of dual ... display. This light source is ... and has the added feature ...
Medicine Products: